Amedisys, Inc. (AMED)
NASDAQ: AMED · Real-Time Price · USD
97.92
-0.11 (-0.11%)
Jun 27, 2025, 4:00 PM - Market closed
Amedisys Stock Forecast
Stock Price Forecast
The 6 analysts that cover Amedisys stock have a consensus rating of "Hold" and an average price target of $100.8, which forecasts a 2.94% increase in the stock price over the next year. The lowest target is $100 and the highest is $101.
Price Target: $100.8 (+2.94%)
Analyst Consensus: Hold
* Price targets were last updated on Apr 16, 2025.
Analyst Ratings
The average analyst rating for Amedisys stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
---|---|---|---|---|---|---|
Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 1 | 1 | 1 | 1 | 1 |
Hold | 4 | 5 | 6 | 5 | 5 | 5 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 5 | 6 | 7 | 6 | 6 | 6 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
RBC Capital | RBC Capital | Buy Reiterates $100 | Buy | Reiterates | $100 | +2.12% | Apr 16, 2025 |
Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +3.15% | Mar 4, 2025 |
Stephens & Co. | Stephens & Co. | Hold Reiterates $101 | Hold | Reiterates | $101 | +3.15% | Feb 12, 2025 |
Deutsche Bank | Deutsche Bank | Strong Buy → Hold Downgrades $101 | Strong Buy → Hold | Downgrades | $101 | +3.15% | Jul 31, 2024 |
Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $101 | Hold | Reiterates | $101 | +3.15% | Jul 25, 2024 |
Financial Forecast
Revenue This Year
2.50B
from 2.35B
Increased by 6.29%
Revenue Next Year
2.63B
from 2.50B
Increased by 5.25%
EPS This Year
4.86
from 1.31
Increased by 271.11%
EPS Next Year
5.31
from 4.86
Increased by 9.28%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
Revenue | 2025 | 2026 | 2027 |
---|---|---|---|
High | 2.6B | 2.8B | 2.8B |
Avg | 2.5B | 2.6B | 2.8B |
Low | 2.4B | 2.5B | 2.7B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 11.4% | 11.0% | 8.1% |
Avg | 6.3% | 5.2% | 5.0% |
Low | 1.2% | -1.0% | 0.9% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | 5.53 | 5.96 | 5.49 |
Avg | 4.86 | 5.31 | 5.33 |
Low | 4.49 | 4.82 | 5.13 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | 322.4% | 22.7% | 3.4% |
Avg | 271.1% | 9.3% | 0.4% |
Low | 242.6% | -0.8% | -3.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.